Ruthenium(III) Complexes of NAMI-A Type with Ligands Based on Lonidamine and Bexarotene as Antiproliferative Agents | SpringerLink
NAMI-A - Wikipedia
Ruthenium(III) compounds in clinical trials KP1019 and NAMI-A. 2,3 | Download Scientific Diagram
Redox-responsive Ru(III) complexes NAMI-A (15), KP1019 (16) KP1339 (17)... | Download Scientific Diagram
Molecular structure of the antimetastatic compound NAMI-A. | Download Scientific Diagram
Arch Clinical Trials - You are not alone... 4.6 million adults (1 in 5) per year experience a mental health condition in the United States. To find a local support group go
Patient Centricity | Segal Trials
Chemical structures of NAMI-A and KP1019. | Download Scientific Diagram
Molecules | Free Full-Text | NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry
Molecules | Free Full-Text | NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry
NAMI New Jersey, N Brunswick, NJ
NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application - Chemical Science (RSC Publishing) DOI:10.1039/C3SC53243G
NAMI-A | Cas# 201653-76-1 - GlpBio
Ruthenium(III) compounds in clinical trials KP1019 and NAMI-A. 2,3 | Download Scientific Diagram
KP1019 - an overview | ScienceDirect Topics
Frontiers | Applications of Ruthenium Complex in Tumor Diagnosis and Therapy
Chemical structures of NAMI-A, KP1019, and KP418. | Download Scientific Diagram
NAMI-A and KP1019/NKP1339 are ruthenium complexes that entered clinical... | Download Scientific Diagram
Upcoming and Previous Events | Segal Trials
Chemical structure of NAMI-A, molecular weight 458.18 g/mol. | Download Scientific Diagram
PDF) NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry
KP1019 - an overview | ScienceDirect Topics
